Nevada § 454.223 Prescription to be written on prescription blank or chart of patient; contents; regulations

Nevada Statutes

§ 454.223 — Prescription to be written on prescription blank or chart of patient; contents; regulations

Nevada § 454.223

Title 40PUBLIC HEALTH AND SAFETY

Ch. 454Poisons;

Dangerous Drugs

This text of Nevada § 454.223 (Prescription to be written on prescription blank or chart of patient; contents; regulations) is published on Counsel Stack Legal Research, covering Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Nev. Rev. Stat. § 454.223 (2026).

Text

1. Except as otherwise provided in subsection 4, each prescription for a dangerous drug must be written on a prescription blank or as an order on the chart of a patient. A chart of a patient may be used to order multiple prescriptions for that patient. 2. A written prescription must contain:

(a)The name of the practitioner, the signature of the practitioner if the prescription was not transmitted orally and the address of the practitioner if not immediately available to the pharmacist;

(b)The classification of his or her license;

(c)The name of the patient, and the address of the patient if not immediately available to the pharmacist;

(d)The name, strength and quantity of the drug or drugs prescribed;

(e)The symptom or purpose for which the drug is prescribed, if included by the pract

Free access — add to your briefcase to read the full text and ask questions with AI

1. Except as otherwise provided in subsection 4, each prescription for a dangerous drug must be written on a prescription blank or as an order on the chart of a patient. A chart of a patient may be used to order multiple prescriptions for that patient.
2. A written prescription must contain:
(a) The name of the practitioner, the signature of the practitioner if the prescription was not transmitted orally and the address of the practitioner if not immediately available to the pharmacist;
(b) The classification of his or her license;
(c) The name of the patient, and the address of the patient if not immediately available to the pharmacist;
(d) The name, strength and quantity of the drug or drugs prescribed;
(e) The symptom or purpose for which the drug is prescribed, if included by the practitioner pursuant to NRS 639.2352 ;
(f) Directions for use; and
(g) The date of issue.
3. Directions for use must be specific in that they must indicate the portion of the body to which the medication is to be applied, or, if to be taken into the body by means other than orally, the orifice or canal of the body into which the medication is to be inserted or injected.
4. The Board shall adopt regulations concerning the electronic transmission of a prescription for a dangerous drug, which must be consistent with federal law and the provisions of NRS 439.581 to 439.597 , inclusive, and the regulations adopted pursuant thereto.